Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−26.4000EUR
−18.97 MEUR
263.00 KEUR
1.12 M
About OXURION
Sector
CEO
Ghoson Pascal
Headquarters
Leuven
Website
Founded
2006
ISIN
BE0974487192
FIGI
BBG000L0P7W7
Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OXUR is 0.3050 EUR — it hasn't changed in the past 24 hours. Watch OXURION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange OXURION stocks are traded under the ticker OXUR.
OXUR stock has risen by 4.99% compared to the previous week, the month change is a −15.51% fall, over the last year OXURION has showed a −96.61% decrease.
OXUR reached its all-time high on Aug 27, 2013 with the price of 297,000.0100 EUR, and its all-time low was 0.2800 EUR and was reached on Oct 11, 2024. View more price dynamics on OXUR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OXUR stock is 6.90% volatile and has beta coefficient of 7.60. Track OXURION stock price on the chart and check out the list of the most volatile stocks — is OXURION there?
Today OXURION has the market capitalization of 407.56 K, it has increased by 12.33% over the last week.
Yes, you can track OXURION financials in yearly and quarterly reports right on TradingView.
OXURION is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
OXUR net income for the last half-year is −3.03 M EUR, while the previous report showed −8.35 M EUR of net income which accounts for 63.73% change. Track more OXURION financial stats to get the full picture.
No, OXUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 19.00 employees. See our rating of the largest employees — is OXURION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OXURION EBITDA is −8.48 M EUR, and current EBITDA margin is −5.12 K%. See more stats in OXURION financial statements.
Like other stocks, OXUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OXURION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OXURION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OXURION stock shows the sell signal. See more of OXURION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.